APA (7th ed.) Citation

Dini, N., Khoshbin, A. P., Aliannejad, R., Bakhshandeh, H., Najafizadeh, K., Mehdizadeh, M., & Amini, S. (2024). A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS). Trials, 25(1), 1. https://doi.org/10.1186/s13063-024-08051-7

Chicago Style (17th ed.) Citation

Dini, Naeemeh, Amin Pastaki Khoshbin, Rasoul Aliannejad, Hooman Bakhshandeh, Katayoun Najafizadeh, Mahshid Mehdizadeh, and Shahideh Amini. "A Placebo-controlled, Crossover Trial to Investigate the Efficacy of Tiotropium Bromide or Placebo Added to Usual Care in Stable Symptomatic Post-hematopoietic Stem Cell Transplantation (HSCT) Bronchiolitis Obliterans Syndrome (BOS)." Trials 25, no. 1 (2024): 1. https://doi.org/10.1186/s13063-024-08051-7.

MLA (9th ed.) Citation

Dini, Naeemeh, et al. "A Placebo-controlled, Crossover Trial to Investigate the Efficacy of Tiotropium Bromide or Placebo Added to Usual Care in Stable Symptomatic Post-hematopoietic Stem Cell Transplantation (HSCT) Bronchiolitis Obliterans Syndrome (BOS)." Trials, vol. 25, no. 1, 2024, p. 1, https://doi.org/10.1186/s13063-024-08051-7.